The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Novartis Pharmaceuticals UK Ltd.
Phase II study of sequential first-line pazopanib (PAZ) followed by everolimus (EVE) in patients (pts) with advanced or metastatic renal cell carcinoma (RCC) (CATChEz Study).
 
Paul L. de Souza
No Relationships to Disclose
 
Shirley Wong
Honoraria - Amgen; Astellas Pharma; Pfizer
Consulting or Advisory Role - Amgen; Astellas Pharma; Pfizer
Speakers' Bureau - Amgen; Astellas Pharma; Pfizer
Research Funding - Astellas Pharma (Inst); Eisai (Inst); Lilly (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Pfizer; Roche
 
Sanjeev Sewak
Speakers' Bureau - Pfizer
Travel, Accommodations, Expenses - Robert Michael Educational Institute
 
Dusan Kotasek
Travel, Accommodations, Expenses - Eisai
 
Bhumsuk Keam
No Relationships to Disclose
 
Jinsoo Chung
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Pfizer
Speakers' Bureau - GlaxoSmithKline; Pfizer
 
Noelle Erbeck
Employment - Novartis Pharmaceuticals UK Ltd.
 
Jackie Han
Employment - Novartis Pharmaceuticals UK Ltd.
 
Luca Dezzani
Employment - Novartis Pharmaceuticals UK Ltd.
 
Qasim Ahmad
No Relationships to Disclose
 
Paul N. Mainwaring
No Relationships to Disclose